Data / Form D filings / Lantern Pharma Inc.
Lantern Pharma Inc.: Form D filings
Lantern Pharma Inc., a pharmaceuticals company in Dallas, TX, filed 3 Form D notices with the SEC between 2019 and 2026. The latest, on May 21, 2026, reports an offering of no set size with nothing sold yet to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1920 MCKINNEY AVENUE, 7TH FLOOR, Dallas, TX, 75201
- Phone
- (972) 277-1136
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Texas
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1763950
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | New notice | Indefinite | $0 | 6 | May 14, 2026 | sec.gov | |
| Mar 18, 2019 | New notice | $6,289,287 | $2,385,005 | $3,904,282 | 5 | Mar 7, 2019 | sec.gov |
| Jan 14, 2019 | New notice | $535,000 | $535,000 | 5 | Dec 18, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Panna Sharma | Executive Officer, Director | Chief Executive Officer, President |
| Donald Jeffrey Keyser | Director | Chairman of the Board |
| David R. Margrave | Executive Officer | Chief Financial Officer, Secretary |
| Kishor G. Bhatia | Executive Officer | Chief Scientific Officer |
| Vijay Chandru | Director | |
| Maria Maccecchini | Director | |
| Lee T. Schalop | Director | |
| David S. Silberstein | Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
- InnovoTEX Inc. $749,951 · Aug 6, 2026
Every Form D from the week of May 18, 2026 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Lantern Pharma Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.